Core Scientific, Inc.
CORZ
$14.73
-$0.43-2.84%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.67M | 16.20M | 12.35M | 15.03M | 27.22M |
| Total Other Revenue | 57.44M | 62.42M | 67.18M | 79.90M | 68.14M |
| Total Revenue | 81.10M | 78.63M | 79.53M | 94.93M | 95.35M |
| Cost of Revenue | 77.20M | 73.60M | 71.31M | 77.93M | 95.51M |
| Gross Profit | 3.91M | 5.03M | 8.21M | 16.99M | -156.00K |
| SG&A Expenses | 63.85M | 56.94M | 40.12M | 50.81M | 40.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -10.96M | -29.80M | 10.69M | 3.56M | 206.00K |
| Total Operating Expenses | 130.09M | 100.75M | 122.12M | 137.32M | 136.06M |
| Operating Income | -48.99M | -22.12M | -42.59M | -42.39M | -40.71M |
| Income Before Tax | -146.54M | -936.64M | 580.90M | -265.17M | -455.13M |
| Income Tax Expenses | 125.00K | 158.00K | 205.00K | 375.00K | 134.00K |
| Earnings from Continuing Operations | -146.66M | -936.80M | 580.69M | -265.54M | -455.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -146.66M | -936.80M | 580.69M | -265.54M | -455.26M |
| EBIT | -48.99M | -22.12M | -42.59M | -42.39M | -40.71M |
| EBITDA | -32.66M | -3.36M | -22.86M | -16.35M | -12.02M |
| EPS Basic | -0.46 | -0.84 | -0.17 | -0.60 | -1.17 |
| Normalized Basic EPS | -0.24 | -1.83 | 1.15 | -0.55 | -0.97 |
| EPS Diluted | -0.46 | -0.85 | -0.17 | -0.60 | -1.17 |
| Normalized Diluted EPS | -0.24 | -1.83 | 1.15 | -0.55 | -0.97 |
| Average Basic Shares Outstanding | 318.56M | 317.99M | 315.20M | 306.15M | 292.49M |
| Average Diluted Shares Outstanding | 318.56M | 317.99M | 315.20M | 306.15M | 292.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |